Search
for
Sort by
Research 31–60 of 520
- Wider clinical applications of fumaric acid esters: A useful option in psoriasis patients with multiple sclerosis
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
- 1113 Targeting anti-inflammatory immunonanocarriers to human and murine neutrophils via Ly6 antigen for psoriasiform dermatitis alleviation
- 22-Year-Old Male with Several Discrete Patches of Hair Loss
- Most recent findings of curative drugs for lower urinary tract symptoms in clinical practice
- Platelet-Rich Plasma for Urologic Conditions: An Early Call for Composition Reporting
- The pharmacological treatment of alopecia areata
- Treatment of actinic cheilitis with ingenol mebutate gel: Experience in four patients
- Study of QuantiFERON’S conversion/reversal phenomena in patients with psoriasis during biological treatment
- Evaluation of risk of SSRI-associated impotence and low libido in men exposed to finasteride
- 8 Finasteride-Associated Suicide and Depression in Men Treated for Hypogonadism and Impotence
- Approaching Erectile Dysfunction in Dermatology Patients
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- 873 The effect of Cilostazol on hair growth: A novel therapeutic option for the treatment of hair loss
- INTERACTION OF α-MELANOCYTE-STIMULATING HORMONE, MELATONIN, CYCLIC AMP AND CYCLIC GMP IN THE CONTROL OF MELANOGENESIS IN HAIR FOLLICLE MELANOCYTES IN VITRO
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Persistent Sexual Dysfunction with Finasteride 1 mg Taken for Hair Loss
- The ‘bald’ phenotype (androgenetic alopecia) is caused by the high glycaemic, high cholesterol and low mineral ‘western diet’
- Therapeutic use of caffeine in dermatology: A literature review
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- The urologic impact of long-term finasteride 1-mg use for androgenic alopecia: a matched-cohort database analysis
- PD49-03 IS TADALAFIL ASSOCIATED WITH DECREASED RISK OF MAJOR ADVERSE CARDIAC EVENTS OR VENOUS THROMBOEMBOLISM IN MEN WITH LOWER URINARY TRACT SYMPTOMS?
- Referee report. For: Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved]
- Anti‐hair loss effect of a shampoo containing caffeine and adenosine
- Tribuloside acts on the PDE/cAMP/PKA pathway to enhance melanogenesis, melanocyte dendricity and melanosome transport
- Role of caffeine in the management of androgenetic alopecia
- Caffeine’s Mechanisms of Action and Its Cosmetic Use
- Caffeine and Its Role in Regulation the Androgenetic Alopecia.
- PD49-02 MEDICATIONS MOST COMMONLY ASSOCIATED WITH ERECTILE DYSFUNCTION: EVALUATION OF THE FOOD AND DRUG ADMINISTRATION NATIONAL PHARMACOVIGILANCE DATABASE
- When two plus two must not equal four